Skip to main content
Log in

Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Although weight loss has been implicated in anti-diabetic effects, sleeve gastrectomy (SG)-mediated anti-diabetic effects are induced through mechanisms beyond weight loss. Our aim was to investigate whether anti-diabetic effects can be achieved by surgically removing a smaller portion of the stomach instead of SG.

Methods

Male 11-week-old Goto–Kakizaki rats (N = 50) were randomized into five groups: sub-sleeve gastrectomy (SSG, only the gastric fundus is removed), SG, sham-operated SSG, sham-operated SG, and control. Body weight, food intake, hormone secretion, and glucose metabolism were measured up to 24 weeks after surgery.

Results

The data showed that (i) both SSG and SG surgeries significantly improved glucose homeostasis, with lower ghrelin levels and higher post-prandial glucagon-like peptide 1, peptide YY, and insulin levels; (ii) SG, but not SSG, produced sustained weight loss and significant reduction of food intake; and (iii) SG induced better long-term diabetic improvement than SSG.

Conclusions

The SSG that only removed the gastric fundus exhibited significant diabetic improvement without weight loss, but did not induce long-term diabetic improvement comparable to that of SG. Our study helps to understand the role of hormones and weight loss in maintaining long-term diabetes improvement after SG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324

    Article  PubMed  Google Scholar 

  2. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblan D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077–1082

    Article  CAS  PubMed  Google Scholar 

  3. Chambers AP, Stefater MA, Wilson-Perez HE, Jessen L, Sisley S, Ryan KK, Gaitonde S, Sorrell JE, Toure M, Berger J, D’Alessio DA, Sandoval DA, Seeley RJ, Woods SC (2011) Similar effects of Roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiol Behav 105:120–123

    Article  CAS  PubMed  Google Scholar 

  4. Karra E, Yousseif A, Batterham RL (2010) Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 21:337–344

    Article  CAS  PubMed  Google Scholar 

  5. Ahn SM, Pomp A, Rubino F (2010) Metabolic surgery for type 2 diabetes. Ann N Y Acad Sci 1212:E37–E45

    Article  PubMed  Google Scholar 

  6. Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE (2010) Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 6:102–109

    Article  PubMed Central  PubMed  Google Scholar 

  7. Pereferrer FS, Gonzalez MH, Rovira AF, Blasco SB, Rivas AM, del Castillo Dejardin D (2008) Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg 18:97–108

    Article  PubMed  Google Scholar 

  8. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401–407

    Article  PubMed  Google Scholar 

  9. Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, Gfrerer L, Ludvik B, Zacherl J, Prager G (2010) Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 20:535–540

    Article  PubMed  Google Scholar 

  10. Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C, Coccia F, Borgonuovo G, De Luca ML, Asprino R, Alessandri G, Casella G, Leonetti F (2011) First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 25:3540–3550

    Article  CAS  PubMed  Google Scholar 

  11. Pech N, Meyer F, Lippert H, Manger T, Stroh C (2012) Complications and nutrient deficiencies two years after sleeve gastrectomy. BMC Surg 12:13

    Article  PubMed Central  PubMed  Google Scholar 

  12. Li F, Zhang G, Liang J, Ding X, Cheng Z, Hu S (2009) Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto–Kakizaki rats. J Gastrointest Surg 13:2302–2308

    Article  PubMed  Google Scholar 

  13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  CAS  PubMed  Google Scholar 

  14. Boza C, Salinas J, Salgado N, Perez G, Raddatz A, Funke R, Pimentel F, Ibanez L (2012) Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg 22:866–871

    Article  PubMed  Google Scholar 

  15. Gagner M, Gumbs AA, Milone L, Yung E, Goldenberg L, Pomp A (2008) Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60 kg/m2. Surg Today 38:399–403

    Article  PubMed  Google Scholar 

  16. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005–1010

    Article  CAS  PubMed  Google Scholar 

  17. Shah PS, Todkar JS, Shah SS (2010) Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 6:138–141

    Article  PubMed  Google Scholar 

  18. Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM (2010) Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 147:664–669

    Article  PubMed  Google Scholar 

  19. Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, Ghatei MA, Bloom SR, Welbourn R, le Roux CW (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 252:966–971

    Article  PubMed  Google Scholar 

  20. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992

    Article  CAS  PubMed  Google Scholar 

  21. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261

    CAS  PubMed  Google Scholar 

  22. Couce ME, Cottam D, Esplen J, Schauer P, Burguera B (2006) Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg 16:870–878

    Article  PubMed  Google Scholar 

  23. Cummings DE, Shannon MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88:2999–3002

    Article  CAS  PubMed  Google Scholar 

  24. Carrasco F, Rojas P, Csendes A, Codoceo J, Inostroza J, Basfi-fer K, Papapietro K, Watkins G, Rojas J, Ruz M (2012) Changes in ghrelin concentrations one year after resective and non-resective gastric bypass: associations with weight loss and energy and macronutrient intakes. Nutrition 28:757–761

    Article  CAS  PubMed  Google Scholar 

  25. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB (2004) Ghrelin: a hormone with multiple functions. Front Neuroendocrinol 25:27–68

    Article  CAS  PubMed  Google Scholar 

  26. Tymitz K, Engel A, McDonough S, Hendy MP, Kerlakian G (2011) Changes in ghrelin levels following bariatric surgery: review of the literature. Obes Surg 21:125–130

    Article  PubMed  Google Scholar 

  27. Dezaki K, Sone H, Yada T (2008) Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 118:239–249

    Article  CAS  PubMed  Google Scholar 

  28. Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J (2012) Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 26:2231–2239

    Article  PubMed  Google Scholar 

  29. Gaitonde S, Kohli R, Seeley R (2012) The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition. J Surg Res 178:33–39

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Mingrone G (2008) Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 18:574–579

    Article  CAS  PubMed  Google Scholar 

  31. Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A (2005) Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 15:1258–1264

    Article  PubMed  Google Scholar 

  32. Wang TT, Hu SY, Gao HD, Zhang GY, Liu CZ, Feng JB, Frezza EE (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247:968–975

    Article  PubMed  Google Scholar 

  33. Masuda T, Ohta M, Hirashita T, Kawano Y, Eguchi H, Yada K, Iwashita Y, Kitano S (2011) A comparative study of gastric banding and sleeve gastrectomy in an obese diabetic rat model. Obes Surg 21:1774–1780

    Article  PubMed  Google Scholar 

  34. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22:740–748

    Article  PubMed Central  PubMed  Google Scholar 

  35. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650–654

    Article  CAS  PubMed  Google Scholar 

  36. Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, Basso N (2010) Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 20:50–55

    Article  PubMed  Google Scholar 

  37. van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP, Pijl H (2007) Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. Am J Physiol Endocrinol Metab 292:E238–E245

    Article  PubMed  Google Scholar 

  38. Konturek SJ, Pepera J, Zabielski K, Konturek PC, Pawlik T, Szlachcic A, Hahn EG (2003) Brain-gut axis in pancreatic secretion and appetite control. J Physiol Pharmacol 54:293–317

    CAS  PubMed  Google Scholar 

  39. Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM (2008) An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 12:2585–2592

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81270888/H0713, No. 81070642/H0713, No. 81370496/H0308, No. 81300286/H0308), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20100131110049), Shandong Provincial Outstanding Medical Academic Professional Program, Natural Science Foundation of Shandong Province Grants (No. ZR2012HQ030), and Graduate Independent Innovation Foundation of Shandong University (No. yzc11068).

Disclosures

Dong Sun, Shaozhuang Liu, Guangyong Zhang, Punsiri Colonne, Chunxiao Hu, Haifeng Han, Mingxia Li and Sanyuan Hu declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanyuan Hu.

Additional information

Dong Sun, Shaozhuang Liu, and Guangyong Zhang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, D., Liu, S., Zhang, G. et al. Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model. Surg Endosc 28, 1010–1018 (2014). https://doi.org/10.1007/s00464-013-3272-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-013-3272-1

Keywords

Navigation